$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes 원문보기

Cancer gene therapy, v.15 no.5, 2008년, pp.331 - 340  

Kim, K S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) ,  Lee, Y K (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) ,  Kim, J S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) ,  Koo, K H (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) ,  Hong, H J (2Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea) ,  Park, Y S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

Anti-tumor-associated glycoprotein (TAG)-72 PEG-immunoliposomes (PILs) were prepared by conjugation of Fab′ fragments of recombinant humanized monoclonal antibody, HuCC49, to sterically stabilize unilamellar liposomes (90–110 nm in diameter) to target TAG-72-overexpressing cancer c...

참고문헌 (39)

  1. Nat Rev Cancer F McCormick 1 130 2001 10.1038/35101008 McCormick F . Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 2001; 1: 130-141. 

  2. PL Felgner 26 1999 Non-Viral Vectors for Gene Therapy Felgner PL . Progress in gene delivery research and development. In: Huang L, Hung MC, Wagner E (eds). Non-Viral Vectors for Gene Therapy. Academic Press: San Diego, CA, 1999, pp 26-38. 

  3. L Huang 3 1999 Non-Viral Vectors for Gene Therapy 10.1016/B978-012358465-6/50013-X Huang L, Viroonchatapan E . Introduction. In: Huang L, Hung MC, Wagner E (eds). Non-Viral Vectors for Gene Therapy. Academic Press: San Diego, CA, 1999, pp 3-22. 

  4. Curr Opin Mol Ther KF Pirollo 2 168 2000 Pirollo KF, Xu L, Chang EH . Non-viral gene delivery for p53. Curr Opin Mol Ther 2000; 2: 168-175. 

  5. BioDrugs G Bendas 15 215 2001 10.2165/00063030-200115040-00002 Bendas G . Immunoliposomes: a promising approach to targeting cancer. BioDrugs 2001; 15: 215-224. 

  6. Curr Drug Deliv P Sapra 2 369 2005 10.2174/156720105774370159 Sapra P, Tyagi P, Allen TM . Ligand-targeted liposomes for cancer treatment. Curr Drug Deliv 2005; 2: 369-381. 

  7. J Pharm Sci K Maruyama 79 978 1990 10.1002/jps.2600791107 Maruyama K, Holmberg E, Kennel SJ, Klibanov A, Torchilin VP, Huang L . Characterization of in vivo immuno-liposome targeting to pulmonary endothelium. J Pharm Sci 1990; 79: 978-984. 

  8. Proc Natl Acad Sci USA D Aragnol 83 2699 1986 10.1073/pnas.83.8.2699 Aragnol D, Leserman LD . Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc Natl Acad Sci USA 1986; 83: 2699-2703. 

  9. Biochim Biophys Acta JTP Derksen 971 127 1988 Derksen JTP, Marselt HWM, Scherphof GL . Uptake and processing of immunoglobulin-coated liposomes by sub-populations of rat liver macrophages. Biochim Biophys Acta 1988; 971: 127-136. 

  10. Biochim Biophys Acta TM Allen 1066 29 1991 10.1016/0005-2736(91)90246-5 Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A . Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29-36. 

  11. Bioconjug Chem HS Kim 15 1095 2004 10.1021/bc049934t Kim HS, Moon J, Kim KS, Choi MM, Lee JE, Heo Y et al. Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chains. Bioconjug Chem 2004; 15: 1095-1101. 

  12. Hybridoma SVS Kashmiri 14 461 1995 10.1089/hyb.1995.14.461 Kashmiri SVS, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH . Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 1995; 14: 461-473. 

  13. FEBS Letters K Maruyama 413 177 1997 10.1016/S0014-5793(97)00905-8 Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M . Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Letters 1997; 413: 177-180. 

  14. Cancer Res C Mamot 65 11631 2005 10.1158/0008-5472.CAN-05-1093 Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer. Cancer Res 2005; 65: 11631-11638. 

  15. Biosci Rep K Maruyama 22 251 2002 10.1023/A:1020138622686 Maruyama K . PEG-immunoliposome. Biosci Rep 2002; 22: 251-266. 

  16. Oncol Res KS Kim 15 343 2005 10.3727/096504005776449707 Kim KS, Park YS . Antitumor effects of angiostatin K 1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method. Oncol Res 2005; 15: 343-350. 

  17. Cancer Gene Ther KS Kim 13 563 2006 10.1038/sj.cgt.7700924 Kim KS, Kim DS, Chung KH, Park YS . Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes. Cancer Gene Ther 2006; 13: 563-571. 

  18. Cancer Gene Ther KS Kim 11 441 2004 10.1038/sj.cgt.7700716 Kim KS, Kim HS, Park JS, Kwon YG, Park YS . Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes. Cancer Gene Ther 2004; 11: 441-449. 

  19. J Control Release HS Kim 115 234 2006 10.1016/j.jconrel.2006.08.003 Kim HS, Song IH, Kim JC, Kim EJ, Jang DO, Park YS . In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O′-dimyristyl-N-lysyl aspartate) and DMKE (O,O′-dimyristyl-N-lysyl glutamate). J Control Release 2006; 115: 234-241. 

  20. Proc Natl Acad Sci USA N Shi 97 7567 2000 10.1073/pnas.130187497 Shi N, Pardridge WM . Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 2000; 97: 7567-7572. 

  21. Mol Ther Y Zhang 6 67 2002 10.1006/mthe.2002.0633 Zhang Y, Zhu C, Pardridge WM . Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002; 6: 67-72. 

  22. J Drug Target C Mamot 14 215 2006 10.1080/10611860600691049 Mamot C, Ritschard R, Kung W, Park JW, Herrmann R, Rochlitz CF . EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. J Drug Target 2006; 14: 215-223. 

  23. Mol Med L Xu 7 726 2001 10.1007/BF03401962 Xu L, Tang WH, Huang CC, Alexander W, Xiang LM, Pirollo KF et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001; 7: 726-738. 

  24. Am J Pathol N Weinder 147 9 1995 Weinder N . Intratumoral microvessle density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19. 

  25. Proc Natl Acad Sci USA HG Enoch 76 145 1979 10.1073/pnas.76.1.145 Enoch HG, Strittmatter P . Formation and properties of 1000- angstrom -diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci USA 1979; 76: 145-149. 

  26. Science E Marshall 286 2244 1999 10.1126/science.286.5448.2244 Marshall E . Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-2245. 

  27. E Wagner 208 1999 Non-Viral Vectors for Gene Therapy Wagner E . Ligand-polycation conjugates for receptor-targeted gene transfer. In: Huang L, Hung MC, Wagner E (eds). Non-Viral Vectors for Gene Therapy. Academic Press: San Diego, CA, 1999, pp 208-227. 

  28. Annu Rev Biomed Eng VP Torchilin 8 343 2006 10.1146/annurev.bioeng.8.061505.095735 Torchilin VP . Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343-735. 

  29. J Urol HN Keer 143 381 1990 10.1016/S0022-5347(17)39970-6 Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT . Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 1990; 143: 381-385. 

  30. Hum Gene Ther PW Cheng 7 275 1996 10.1089/hum.1996.7.3-275 Cheng PW . Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996; 7: 275-282. 

  31. Biochim Biophys Acta TM Allen 1237 99 1995 10.1016/0005-2736(95)00085-H Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S . A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1995; 1237: 99-108. 

  32. Biochim Biophys Acta DL Iden 1513 207 2001 10.1016/S0005-2736(01)00357-1 Iden DL, Allen TM . In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 2001; 1513: 207-216. 

  33. Curr Opin Mol Ther DD Lasic 1 177 1999 Lasic DD, Vallner JJ, Working PK . Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther 1999; 1: 177-185. 

  34. Proc Natl Acad Sci USA JW Park 92 1327 1995 10.1073/pnas.92.5.1327 Park JW, Hong K, Carter P, Asgari H, Guo LY, Keller GA et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA 1995; 92: 1327-1331. 

  35. Cancer Lett C Brignolea 197 199 2003 10.1016/S0304-3835(03)00099-5 Brignolea C, Marimpietria D, Gambinib C, Allenc TM, Ponzonia M, Pastorino F . Development of Fab′ fragments of anti-GD2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma. Cancer Lett 2003; 197: 199-204. 

  36. Int J Pharm K Ng 193 157 2000 10.1016/S0378-5173(99)00330-0 Ng K, Zhao L, Liu Y, Mahapatro M . The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome. Int J Pharm 2000; 193: 157-166. 

  37. Ann N Y Acad Sci PL Felgner 772 126 1995 10.1111/j.1749-6632.1995.tb44738.x Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J et al. Improved cationic lipid formulations for in vivo gene therapy. Ann N Y Acad Sci 1995; 772: 126-139. 

  38. Biochem Biophys Res Commun NK Egilmez 40 169 1996 10.1006/bbrc.1996.0564 Egilmez NK, Iwanuma Y, Bankert RB . Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem Biophys Res Commun 1996; 40: 169-173. 

  39. Hum Gene Ther RI Mahato 9 2083 1998 10.1089/hum.1998.9.14-2083 Mahato RI, Anwer K, Tagliaferri F, Meaney C, Leonard P, Wadhwa MS et al. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther 1998; 9: 2083-2099. 

LOADING...

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로